![PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network](https://www.researchgate.net/publication/336972259/figure/fig3/AS:962802894262279@1606561506425/Kaplan-Meyer-curve-of-time-from-last-chemotherapy-cycle-to-date-of-progression-or-death_Q320.jpg)
PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network
![The emergence of new prognostic scores in lung cancer patients with spinal metastasis: A 12-year single-center retrospective study The emergence of new prognostic scores in lung cancer patients with spinal metastasis: A 12-year single-center retrospective study](https://www.jcancer.org/v12/p5644/jcav12p5644g003.jpg)
The emergence of new prognostic scores in lung cancer patients with spinal metastasis: A 12-year single-center retrospective study
![Cancers | Free Full-Text | Spread Through Air Spaces (STAS) Is an Independent Prognostic Factor in Resected Lung Squamous Cell Carcinoma Cancers | Free Full-Text | Spread Through Air Spaces (STAS) Is an Independent Prognostic Factor in Resected Lung Squamous Cell Carcinoma](https://www.mdpi.com/cancers/cancers-14-02281/article_deploy/html/images/cancers-14-02281-g001.png)
Cancers | Free Full-Text | Spread Through Air Spaces (STAS) Is an Independent Prognostic Factor in Resected Lung Squamous Cell Carcinoma
![Cancers | Free Full-Text | Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence Cancers | Free Full-Text | Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence](https://www.mdpi.com/cancers/cancers-14-03483/article_deploy/html/images/cancers-14-03483-g001-550.jpg)
Cancers | Free Full-Text | Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence
![Clinical and genomic features of Chinese lung cancer patients with germline mutations | Nature Communications Clinical and genomic features of Chinese lung cancer patients with germline mutations | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-28840-5/MediaObjects/41467_2022_28840_Fig1_HTML.png)
Clinical and genomic features of Chinese lung cancer patients with germline mutations | Nature Communications
![Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525730420300012-gr2.jpg)
Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect
![Viruses | Free Full-Text | Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma Viruses | Free Full-Text | Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma](https://www.mdpi.com/viruses/viruses-15-00198/article_deploy/html/images/viruses-15-00198-g001.png)
Viruses | Free Full-Text | Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma
![Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525730420300012-gr1.jpg)
Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect
![SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019) | Clinical and Translational Oncology SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019) | Clinical and Translational Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12094-020-02295-w/MediaObjects/12094_2020_2295_Fig2_HTML.png)
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019) | Clinical and Translational Oncology
![P199 Merseyside & Cheshire Cancer Network (MCCN) Audit: Survival Analysis of Lung Cancer Patients with a Performance Status of 3 (PS3) Based Upon the Reason For Their Poor Performance Status and Whether P199 Merseyside & Cheshire Cancer Network (MCCN) Audit: Survival Analysis of Lung Cancer Patients with a Performance Status of 3 (PS3) Based Upon the Reason For Their Poor Performance Status and Whether](https://thorax.bmj.com/content/thoraxjnl/67/Suppl_2/A151.1/F1.large.jpg)
P199 Merseyside & Cheshire Cancer Network (MCCN) Audit: Survival Analysis of Lung Cancer Patients with a Performance Status of 3 (PS3) Based Upon the Reason For Their Poor Performance Status and Whether
![PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network](https://i1.rgstatic.net/publication/336972259_Treatment_beyond_four_cycles_of_first_line_Platinum_and_Etoposide_chemotherapy_in_real-life_patients_with_stage_IV_Small_Cell_Lung_Cancer_a_retrospective_study_of_the_Merseyside_and_Cheshire_Cancer_ne/links/5dbcd62b299bf1a47b0a4680/largepreview.png)
PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network
![Basic clinical background on small cell lung cancer (SCLC) (in the text... | Download Scientific Diagram Basic clinical background on small cell lung cancer (SCLC) (in the text... | Download Scientific Diagram](https://www.researchgate.net/publication/359405081/figure/fig1/AS:1147710069575686@1650646812678/Basic-clinical-background-on-small-cell-lung-cancer-SCLC-in-the-text-box-left-with_Q320.jpg)
Basic clinical background on small cell lung cancer (SCLC) (in the text... | Download Scientific Diagram
![Epidemiological Characteristics, EGFR Status and Management Patterns of Advanced Non-small Cell Lung Cancer Patients: The Greek REASON Observational Registry Study | Anticancer Research Epidemiological Characteristics, EGFR Status and Management Patterns of Advanced Non-small Cell Lung Cancer Patients: The Greek REASON Observational Registry Study | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/38/6/3735/F4.large.jpg)